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1. Introduction 
Chemical modification of functional groups in 
receptors for neurotransmitters and neuromodulators 
can shed light on the fine structure of the receptor 
binding site(s). No information is yet available on the 
identity of amino acid residues in the binding site(s) 
of brain benzodiazepine r ceptors. Evidence was pro- 
vided in [ 1 ] for the involvement ofa tyrosyl residue in 
the binding of indoles and benzodiazepines to human 
serum albumin. It is thus pertinent to investigate 
whether tyrosine also plays a role in the binding of 
benzodiazepines to their brain receptors. Here, we 
report hat the chemical modification of both mem- 
brane-bound and solubilized brain benzodiazepine 
receptors by tetranitromethane and by N-acetylimid- 
azole results in loss of the ability of the receptors to 
bind [3HI flunitrazepam ([3H] FNZ). Our results 
strongly suggest that tyrosine is involved in the binding 
of benzodiazepines to their receptors in the brain. 
2. Experimental 
2.1. Chemicals 
[3H] Flunitrazepam ([3H] FNZ, 84.8 Ci/mmol) was 
obtained from New England Nuclear (Boston MA). 
Sodium dexoxycholate (DOC) and tetranitromethane 
(TNM) were obtained from Fluka (Buchs). Diazepam 
was donated by Assia (Jerusalem) nitrazepam was 
donated by Ikapharm (Kfar Saba) and RO-5-4864 
was the gift of Dr H. M6hler (F. Hoffmann-La Roche, 
Basel). 7-Aminobutyric acid (GABA), N-ethylmale- 
imide (NEM) and p-chloromercuriphenylsulfonic acid 
(PCMPS) were purchased from Sigma (St Louis MO). 
hnidazole was from British Drug Houses (Poole) and 
acetic anhydride was from Frutarom (Haifa).N-Acetyl- 
imidazole was synthesized by reacting imidazole with 
acetic anhydride and evaporating the excess of acetic 
anhydride under vacuum. Sephadex G-75 was obtained 
from Pharmacia (Uppsala). All other chemicals were 
of analytical grade. 
2.2. Methods 
Crude washed membranes were prepared from calf 
cerebral cortex as in [2]. The membranes were sus- 
pended in 50 mM Tris-HC1 (pH 8.0) or in 50 mM 
Tris-HC1 (pH 6.5). Benzodiazepine r ceptors were 
solubilized by 0.5% DOC in 25 mM Tris-HC1 (pH 8.0) 
as in [3]. [3H]FNZ binding (final conc. 5 nM) was 
assayed at 0°C using the filtration procedure for par- 
ticulate receptors and the combined ammonium sul- 
fate precipitation and filtration procedure for soluble 
receptors [3]. 
Nitration with TNM at pH 8 (unless otherwise 
indicated) was according to [4]. Aliquots of TNM in 
ethanol were added to the receptor preparations to
yield a final TNM concentration f2.5-20 mM, while 
keeping ethanol at <5%. The appropriate amount of 
ethanol without TNM was added to control aliquots. 
Incubation with gentle mixing was carried out at con- 
stant pH at room temperature. Nitration of particulate 
receptor preparations was followed by direct dilution 
(20-fold) of the treated aliquots into the assay mix- 
ture at 0°C. Nitration of soluble receptors was ter- 
minated by separating the reagent from the receptor 
molecules on a Sephadex G-75 column pre-equilibrated 
with 0.25% DOC, 25 mM Tris-HC1 (pH 7.2). The 
columns were prepared in 3 ml plastic syringes and 
the receptor was eluted by centrifugation at1000 rev./ 
min for 3 min at 4°C. The same gel Filtration proce- 
dure was also employed to separate the solubilized 
receptor from various ligands used in protection 
experiments, asdescribed below. 
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Acetylat ion with N-acetytimidazole was done as in 
[5]. Membranes were prepared in 50 mM sodium borate 
buffer (pH 7.5) and incubated with 10 mM N-acetyl- 
imidazole at room temperature, with gentle mixing. 
The reaction was fol lowed by 20-fold di lution of  ali- 
quots into the assay mixture at 0°C. Deacetylat ion 
was performed by incubating the acetylated mem- 
branes with 80 mM hydroxylamine at 3 0°C for various 
times up to 2 h. 
Alkylat ion with NEM (5 mM) or PCMPS (1 mM) 
was carried out for 30 rain at room temperature in 
the presence o f  60 mM NaC1, 25 mM Tris-HC1 (pH 7.2). 
3. Results and discussion 
React ion of  both particulate and solubilized calf 
cortex preparations with TNM resulted in a gradual 
loss o f  [3H] FNZ-binding capacity (fig. 1,2). Very little 
[all] FNZ binding was detected after 1 h incubation 
with >~5 mM TNM, at pH 8.0. Binding of  [3H]FNZ to 
control  aliquots treated with ethanol alone was not 
significantly altered even after 3 h (f ig. l) .  Binding 
capacity o f  solubilized receptors was less stable under 
these experimental  condit ions (fig.2A, see also [3]); 
the effect o f  TNM in these preparations was even more 
pronounced and 2.5 mM TNM caused a 50% reduction 
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Fig.2. Effect of incubation with TNM on the subsequently 
measured [ 3 H ] FNZ-binding capacity of DOC-solubilized ben- 
zodiazepine receptor preparation. The incubation with TNM 
was carried out at room temperature at pH 8.0 for the indicated 
times: (A) (o - -o ) ,  no TNM present; (e o), incubation in 
the presence of 2.5 nM TNM; (B) Binding capacity relative to 
control, calculated from (A). 
We have tested the ability of  benzodiazepines and 
of  GABA, which has been reported to interact with 
the benzodiazepine r ceptor [3,6], to protect against 
the TNM effect (table 1). Incubation with diazepam 
protected against he loss of  binding activity induced 
by TNM, whereas the pharmacologically inactive ben- 
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Fig.1. Effect of incubation with TNM on the subsequently 
measured [ 3H ] FNZ-binding capacity of a particulate benzo- 
dizepine receptor preparation. The incubation with TNM was 
carried out a room temperature atpH 8 for the indicated 
times in the absence of TNM (o - -o ) ,  or in the presence of 
2.5 mM TNM (e - -e ) ,  5 mM TNM (z~__~), 10 mM TNM 
(A__A) or 20 mM TNM (D- -u ) .  
Table 1 
Effect of various ligands on the modification of 
benzodiazepine receptors by TNM 
Ligand Residual activity (%) 
Exp. I Exp. 11 
48 34 
5 X 10 -6 M Diazepam 69 80 
10 -s M GABA 58 55 
5 X 10 -6 M Diazepam + 
10 -5 M GABA 111 106 
5 X 10 -6 M Nitrazepam +
10 -s M GABA - 118 
10 -4 M RO-5-4864 46 35 
Aliquots of a DOC-solubilized benzodiazepine r ceptor prep- 
aration were incubated with the indicated ligands for 60 min 
at 0°C. TNM was than added to final conc. 2.5 mM (exp. I) 
or 5.0 mM (exp. I1) and incubation was further carried on for 
30 min at room temperature. Aliquots of the receptor were 
separated from the ligands and from TNM as in section 2.2. 
Values are presented as percent of [3H]FNZ-binding activity, 
assayed subsequently, relative to control without TNM 
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zodiazepine, RO-5-4864, was not effective. GABA 
also provided some protection against nitration; com- 
binations of GABA and a pharmacologically active 
benzodiazepine (diazepam or nitrazepam) were most 
effective (tablel). 
TNM may also modify cysteine or, though less 
likely, tryptophan residues [7]. Nitration of tyrosine 
is expected to proceed much slower at pH 6.5 than at 
pH 8.0, whereas nitration of cysteine is efficient at 
the lower pH [4,7]. Tryptophan isnot expected to 
react below pH 7 [7]. We have subjected an aliquot of 
a particulate receptor preparation to treatment with 
5 mM TNM at pH 6.5, and found that loss of [3H]- 
FNZ-binding activity, although significant, was much 
slower than at pH 8.0. Thus, 90% of the [3H] FNZ- 
binding capacity was lost after 1 h at pH 8.0, while 
the corresponding value at pH 6.5 was 50%. This result 
argues against he involvement of cysteine or tryp- 
tophan in the reaction. In addition, we have incubated 
aliquots of a particulate receptor preparation for 1.5 h 
at room temperature in the presence of 1 mM PCMPS, 
5 mM NEM or 5 mM TNM. [all] FNZ-binding, relative 
to control, was found to be 112%, 116% and 10%, 
respectively. The latter results render the possibility 
that TNM modifies a cysteine residue very unlikely. 
To further support he hypothesis that a modified 
tyrosine is responsible for the inactivation of [aH]- 
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Fig.3. Effect of incubation with N-acetylimidazole n the 
subsequently measured [ 3H ] FNZ-binding capacity of a par- 
ticulate benzodiazepine receptor preparation. I cubation 
with N-acetylirnidazole was carried out at room temperature 
for 30 min with 10 mM reagent (e e) or withoutit (o- -o) .  
After 30 min (arrow) hydroxylamine (final conc. 80 mM) 
was added to both preparations. 
imidazole, which acetylates phenolic groups [5], on 
the benzodiazepine receptor. Incubation withN-acetyl- 
imidazole led to a gradual loss of [3H] FNZ-binding 
capacity, which was partially reversed by deacetyla- 
tion with hydroxylamine (fig.3). 
Taken together, our results uggest that a tyrosyl 
residue (or residues) is located at, or in proximity to, 
the ligand binding site(s) of the brain receptors for 
benzodiazepines. It is plausible to assume that the 
modified tyrosine is exposed to the outer surface of 
the receptor since N-acetylimidazole was reported not 
to react with buried tyrosine residues [5]. In [1], a 
tyrosine residue was reported to be involved in the 
binding of benzodiazepines and indoles, e.g., L-tryp- 
tophan, to human serum albumin, and evidence was 
also that in the latter macromolecule the nitrated 
amino acid is not tryptophan. The similarity between 
the binding sites of serum albumin and brain benzo- 
diazepine receptors i limited, since the affinity of 
benzodiazepines to brain receptors i several orders of 
magnitude higher than their affinity for serum albumin, 
and the binding of [3H] FNZ to calf brain receptor is 
not displaced even by 10 -2 M L-tryptophan. 
The protection against he inactivation of solubilized 
receptors by TNM, provided by GABA and a combina- 
tion of GABA and a benzodiazepine, also corroborates 
previous reports that the DOC-solubllized benzodiaz- 
epine receptor bears a GABA recognition site [3,8]. 
However, the relationship between the benzodiazepine 
and the GABA sites (e.g., do they reside in close 
proximity or on separate polypeptides) aswell as direct 
evidence for the identity and the location of the tyrosyl 
residue(s) involved in ligand binding to the receptor, 
must await the purification of the receptor molecule. 
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